| Title |
Prospective, Randomized, Single-Blinded Comparative Trial of Intravenous Levetiracetam Versus Phenytoin for Seizure Prophylaxis
|
|---|---|
| Published in |
Neurocritical Care, November 2009
|
| DOI | 10.1007/s12028-009-9304-y |
| Pubmed ID | |
| Authors |
Jerzy P. Szaflarski, Kiranpal S. Sangha, Christopher J. Lindsell, Lori A. Shutter |
| Abstract |
Anti-epileptic drugs are commonly used for seizure prophylaxis after neurological injury. We performed a study comparing intravenous (IV) levetiracetam (LEV) to IV phenytoin (PHT) for seizure prophylaxis after neurological injury. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 273 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 2% |
| Ethiopia | 1 | <1% |
| Brazil | 1 | <1% |
| South Africa | 1 | <1% |
| Canada | 1 | <1% |
| France | 1 | <1% |
| Belgium | 1 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Japan | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 258 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 41 | 15% |
| Other | 39 | 14% |
| Student > Doctoral Student | 26 | 10% |
| Student > Bachelor | 26 | 10% |
| Student > Ph. D. Student | 23 | 8% |
| Other | 85 | 31% |
| Unknown | 33 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 151 | 55% |
| Neuroscience | 31 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 7% |
| Nursing and Health Professions | 8 | 3% |
| Agricultural and Biological Sciences | 4 | 1% |
| Other | 18 | 7% |
| Unknown | 43 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2019.
All research outputs
#1,764,781
of 22,661,413 outputs
Outputs from Neurocritical Care
#133
of 1,488 outputs
Outputs of similar age
#5,699
of 93,980 outputs
Outputs of similar age from Neurocritical Care
#1
of 16 outputs
Altmetric has tracked 22,661,413 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,488 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,980 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.